Cardiol Res. 2017 Apr;8(2):36-43. doi: 10.14740/cr545w. Epub 2017 May 03.

Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients.

Cardiology research

Takashi Hitsumoto

PMID: 28515820 PMCID: PMC5421484 DOI: 10.14740/cr545w

Abstract

BACKGROUND: The arterial velocity pulse index (AVI) is explored as a novel marker of atherosclerosis using pulse wave analysis in clinical settings. Recent clinical studies have reported that the level of high-sensitivity troponin T (hs-cTnT) is an important biomarker in hypertensive patients. The aim of this study was to clarify the impact of AVI on hs-cTnT in these patients.

METHODS: This study enrolled 455 hypertensive outpatients (181 males and 274 females; mean age, 65 ± 11 years (mean ± standard deviation)) without a history of cardiovascular events. AVI and hs-cTnT levels were measured using a commercial device, and relations among various clinical parameters, including AVI and hs-cTnT, were examined.

RESULTS: Hs-cTnT was detected in 405 patients (89.0%). AVI was significantly higher in patients with detectable hs-cTnT than in those without (28 ± 7 vs. 24 ± 8, respectively, P < 0.001). In patients with detectable hs-cTnT, there was a significant positive correlation between AVI and hs-cTnT (r = 0.42, P < 0.001). Furthermore, multiple regression analyses revealed that AVI was an independent variable when hs-cTnT was used as a subordinate factor. On the other hand, hs-cTnT age, Cornell electrocardiographic voltage, height, urinary albumin excretion, pulse rate, and derivatives of reactive oxygen metabolites test were independent variables when AVI was used as a subordinate factor.

CONCLUSION: The results of this study indicate that AVI reflects features of arterial wave reflection and is an important factor for hs-cTnT elevation in hypertensive patients.

Keywords: Arterial velocity pulse index; Cardiovascular risk factor; High-sensitivity troponin T; Hypertension

References

1. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
2. Int J Cardiol. 2015 Jan 15;178:226-31 - PubMed
3. PLoS One. 2015 Aug 03;10(8):e0134245 - PubMed
4. J Nippon Med Sch. 2015 ;82(6):274-80 - PubMed
5. J Hypertens. 2013 Apr;31(4):805-12 - PubMed
6. J Hum Hypertens. 2004 Jun;18(6):403-9 - PubMed
7. Rev Endocr Metab Disord. 2010 Mar;11(1):31-9 - PubMed
8. Diabetologia. 2006 Jun;49(6):1434-46 - PubMed
9. J Cardiol. 2011 Nov;58(3):226-31 - PubMed
10. Circulation. 2011 Apr 5;123(13):1367-76 - PubMed
11. Hypertens Res. 2008 Jul;31(7):1293-8 - PubMed
12. J Am Coll Cardiol. 1997 Dec;30(7):1863-71 - PubMed
13. Circulation. 2015 Sep 1;132(9):825-33 - PubMed
14. Clin Exp Nephrol. 2007 Mar;11(1):41-50 - PubMed
15. Am J Hypertens. 2008 Sep;21(9):989-93 - PubMed
16. J Physiol. 2000 May 15;525 Pt 1:263-70 - PubMed
17. Int J Cardiol. 2015;189:244-6 - PubMed
18. J Am Coll Cardiol. 1998 Apr;31(5):1103-9 - PubMed
19. Circulation. 2006 Mar 7;113(9):1213-25 - PubMed
20. BMC Cardiovasc Disord. 2016 Nov 7;16(1):211 - PubMed
21. Clin Chem Lab Med. 2011 Nov;49(11):1899-906 - PubMed
22. Kardiol Pol. 2012;70(3):223-31 - PubMed
23. Int Angiol. 1999 Jun;18(2):127-30 - PubMed
24. Hypertension. 2015 Jan;65(1):78-84 - PubMed
25. Genet Mol Res. 2014 Jul 07;13(3):5143-53 - PubMed
26. Atherosclerosis. 2011 Oct;218(2):493-8 - PubMed
27. Clin Chem. 2009 Jan;55(1):101-8 - PubMed
28. J Cardiol. 2017 Jan;69(1):30-37 - PubMed
29. Ren Fail. 2015 Mar;37(2):254-61 - PubMed
30. Circulation. 2007 Sep 11;116(11):1242-9 - PubMed
31. Am J Hypertens. 2006 Jan;19(1):27-32 - PubMed
32. Lancet. 1992 Aug 8;340(8815):319-23 - PubMed
33. Anatol J Cardiol. 2015 May;15(5):396-403 - PubMed
34. Diabetes Metab Syndr Obes. 2015 Mar 10;8:157-62 - PubMed
35. PLoS One. 2015 Aug 24;10(8):e0135747 - PubMed
36. Pulse (Basel). 2015 Sep;3(2):98-105 - PubMed
37. Am Heart J. 2010 Jun;159(6):972-8 - PubMed
38. Diabetologia. 1985 Jul;28(7):412-9 - PubMed
39. J Nippon Med Sch. 2012;79(6):422-9 - PubMed

Publication Types

• Journal Article